Drug profile · INN
viloxazine hydrochloride
VILOXAZINE HYDROCHLORIDE
viloxazine hydrochloride (VILOXAZINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with SUPERNUS PHARMACEUTICALS, INC.. Route of administration: oral. Current US regulatory status: approved.
Drug details — viloxazine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 18
- Programs
- 0
- Data quality
- 0.89
Quick answer
viloxazine hydrochloride (VILOXAZINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with SUPERNUS PHARMACEUTICALS, INC.. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 12121523
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
granted -
US 11458143
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
granted -
US 11324753
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
granted -
US 10160733
Methods for producing viloxazine salts and novel polymorphs thereof
granted -
US 10005743
Methods for producing viloxazine salts and novel polymorphs thereof
granted -
US 9662338
Formulations of viloxazine
granted -
US 9603853
Formulations of viloxazine
granted -
US 9434703
Viloxazine compositions
granted -
US 9403783
Methods for producing viloxazine salts and novel polymorphs thereof
granted -
US 9358204
Formulations of viloxazine
granted -
US 9308176
Less abusable pharmaceutical preparations
granted -
US 8808714
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
granted -
US 8709476
Compositions of quaternary ammonium compounds containing bioavailability enhancers
granted -
US 7910128
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
granted -
US 7781448
Once daily dosage forms of trospium
granted -
US 7763635
Once daily dosage forms of trospium
granted -
US 7611728
Osmotic delivery of therapeutic compounds by solubility enhancement
granted -
US 7410978
Once daily dosage forms of trospium
granted
Frequently asked questions
What is viloxazine hydrochloride?
viloxazine hydrochloride (VILOXAZINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with SUPERNUS PHARMACEUTICALS, INC.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for viloxazine hydrochloride?
VILOXAZINE HYDROCHLORIDE is a marketed brand name for viloxazine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of viloxazine hydrochloride?
viloxazine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.